Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Nihon Chouzai Co ( (JP:3341) ) just unveiled an update.
Nihon Chouzai has announced the delisting of its shares from the Tokyo Stock Exchange Prime Market effective December 19, 2025, following shareholder approval for share consolidation changes during an extraordinary general meeting. The company expressed gratitude to stakeholders and emphasized its commitment to enhancing corporate value, supporting society, and further strengthening its mission of offering the closest possible support to people.
The most recent analyst rating on (JP:3341) stock is a Hold with a Yen3834.00 price target. To see the full list of analyst forecasts on Nihon Chouzai Co stock, see the JP:3341 Stock Forecast page.
More about Nihon Chouzai Co
Nihon Chouzai Co., Ltd. operates in the healthcare industry, specializing in pharmaceutical dispensing, drug manufacturing, and medical consulting services, with a strong focus on providing accessible healthcare solutions in Japan.
Average Trading Volume: 57,718
Technical Sentiment Signal: Buy
Current Market Cap: Yen113.9B
Learn more about 3341 stock on TipRanks’ Stock Analysis page.